多氨基受体D3基因的多态性与复发性复发性硬化症患者的疾病进展率相关
Marco Ferrari1, Domizia Vecchio2,3, Sandra D'Alfonso3,4
1Center of Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Genes
|June 27, 2024
概括
多巴胺受体中的特定基因变异与多发性硬化症 (MS) 中更快的残疾进展有关. 这一发现可能有助于预测MS恶化,并指导个性化治疗策略.
科学领域:
- 神经免疫学 神经免疫学
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 多发性硬化症 (MS) 是一种影响中枢神经系统的慢性自身免疫性疾病,其特征是不可预测的残疾进展.
- 多巴胺 (DA) 在免疫调节中发挥作用,对MS的发病和治疗有影响.
- 多巴胺受体 (DR) 基因的遗传变异与MS进展之间的关联在很大程度上尚未被探索.
研究的目的:
- 研究多巴胺受体基因中的功能单核酸多态 (SNPs) 与多发性硬化症患者残疾进展之间的潜在联系.
主要方法:
- 被诊断为复发性缓解性多发性硬化症 (RRMS) 的高加索患者被招募参加该研究.
- 使用多发性硬化症严重性评分 (MSSS) 量化疾病进展.
主要成果:
- 患有DRD3基因中rs6280和rs1800828SNP的G/G基因型的患者表现出明显更高的MSSS得分.
- 这表明,与其他基因型相比,特定的DRD3基因型与更严重的MS进展之间存在相关性.
结论:
- 这些发现表明,特定的DRD3基因变异可能作为评估MS进展的潜在标志物.
- 在更大的前性研究中进一步验证可能会为新的治疗策略和个性化MS管理铺平道路.
- 识别这些标志物可以改善患者的福祉,并减少护理人员的负担.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Human Genetics
556
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
556
Parkinson's Disease: Overview
523
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
523


